Matrix metalloproteinase inhibitors

Details for Australian Patent Application No. 2001238319 (hide)

Owner Bristol-Myers Squibb Pharma Company

Inventors Rajopadhye, Milind; Carpenter Jr., Alan P.

Agent Callinan

Pub. Number AU-B-2001238319

PCT Pub. Number WO01/60416

Priority 60182712 15.02.00 US

Filing date 15 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 6 April 2006

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

6 April 2006 Application Accepted

  Published as AU-B-2001238319

3 August 2006 Standard Patent Sealed

10 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001238320

2001238318